Cereno Scientific AB
Develops epigenetic therapies for rare cardiovascular and pulmonary diseases.
CRNO | ST
Overview
Corporate Details
- ISIN(s):
- SE0008241541 (+3 more)
- LEI:
- 549300VX8KTMYDS6NM84
- Country:
- Sweden
- Address:
- BioVentureHub, 431 83 Mölndal
- Website:
- https://cerenoscientific.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Cereno Scientific AB is a clinical-stage biotechnology company focused on developing innovative, disease-modifying treatments for rare cardiovascular and pulmonary diseases. The company's pipeline includes drug candidates in both clinical and preclinical phases. Its clinical portfolio utilizes epigenetic modulation through an HDACi (histone deacetylase inhibitor) platform. A key preclinical asset, CS585, is a novel prostacyclin (IP) receptor agonist. Cereno's strategy targets diseases with significant unmet medical needs, aiming to provide high treatment value to patients while leveraging a business model that allows for potentially shorter development timelines and accelerated market entry.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Cereno Scientific AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Cereno Scientific AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-16 | Sten Sörensen | Other | Other | 866,665 | 86,666.50 SEK |
| 2024-11-25 | Security Holding Sverige AB | Other | Buy | 20,000 | 99,800.00 SEK |
